These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 28388717

  • 1. Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.
    Nestor M, Ablon G, Pickett A.
    Aesthet Surg J; 2017 May 01; 37(suppl_1):S20-S31. PubMed ID: 28388717
    [Abstract] [Full Text] [Related]

  • 2. The Practical Use of AbobotulinumtoxinA in Aesthetics.
    Kane MA, Monheit G.
    Aesthet Surg J; 2017 May 01; 37(suppl_1):S12-S19. PubMed ID: 28388719
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC.
    Am J Clin Dermatol; 2010 May 01; 11(3):183-99. PubMed ID: 20369902
    [Abstract] [Full Text] [Related]

  • 4. A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.
    Wilson AJ, Chang B, Taglienti AJ, Chin BC, Chang CS, Folsom N, Percec I.
    Plast Reconstr Surg; 2016 May 01; 137(5):1424-1433. PubMed ID: 27119918
    [Abstract] [Full Text] [Related]

  • 5. New Uses of AbobotulinumtoxinA in Aesthetics.
    Schlessinger J, Gilbert E, Cohen JL, Kaufman J.
    Aesthet Surg J; 2017 May 01; 37(suppl_1):S45-S58. PubMed ID: 28388720
    [Abstract] [Full Text] [Related]

  • 6. AbobotulinumtoxinA: A 25-Year History.
    Monheit GD, Pickett A.
    Aesthet Surg J; 2017 May 01; 37(suppl_1):S4-S11. PubMed ID: 28388718
    [Abstract] [Full Text] [Related]

  • 7. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
    Wortzman MS, Pickett A.
    Aesthet Surg J; 2009 Nov 01; 29(6 Suppl):S34-42. PubMed ID: 19945003
    [Abstract] [Full Text] [Related]

  • 8. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I: Upper facial wrinkles.
    Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaén P, Monheit GD, Rzany B, Viel M.
    J Eur Acad Dermatol Venereol; 2010 Nov 01; 24(11):1278-84. PubMed ID: 20337830
    [Abstract] [Full Text] [Related]

  • 9. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial.
    Hexsel D, Brum C, do Prado DZ, Soirefmann M, Rotta FT, Dal'Forno T, Rodrigues TC.
    J Am Acad Dermatol; 2012 Aug 01; 67(2):226-32. PubMed ID: 22041253
    [Abstract] [Full Text] [Related]

  • 10. Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles.
    Michaels BM, Csank GA, Ryb GE, Eko FN, Rubin A.
    Aesthet Surg J; 2012 Jan 01; 32(1):96-102. PubMed ID: 22231417
    [Abstract] [Full Text] [Related]

  • 11. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part II: Wrinkles on the middle and lower face, neck and chest.
    Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaén P, Monheit GD, Rzany B, Viel M.
    J Eur Acad Dermatol Venereol; 2010 Nov 01; 24(11):1285-95. PubMed ID: 20569284
    [Abstract] [Full Text] [Related]

  • 12. Clinical Assessment of 2 Licensed AbobotulinumtoxinA Injection Volumes for the Treatment of Glabellar Lines.
    Kaufman J, Cohen JL, Peredo MI, Jonas B, Down R, Nogueira A.
    Dermatol Surg; 2019 Oct 01; 45(10):1274-1284. PubMed ID: 30893159
    [Abstract] [Full Text] [Related]

  • 13. Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review.
    Cohen JL, Scuderi N.
    Aesthet Surg J; 2017 May 01; 37(suppl_1):S32-S44. PubMed ID: 28388721
    [Abstract] [Full Text] [Related]

  • 14. Overview of Botulinum Toxins for Aesthetic Uses.
    Gart MS, Gutowski KA.
    Clin Plast Surg; 2016 Jul 01; 43(3):459-71. PubMed ID: 27363760
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    Lancet Neurol; 2015 Oct 01; 14(10):992-1001. PubMed ID: 26318836
    [Abstract] [Full Text] [Related]

  • 16. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
    Matarasso A, Shafer D.
    Aesthet Surg J; 2009 Nov 01; 29(6 Suppl):S72-9. PubMed ID: 19945008
    [Abstract] [Full Text] [Related]

  • 17. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes.
    Chang BL, Wilson AJ, Taglienti AJ, Chang CS, Folsom N, Percec I.
    Aesthet Surg J; 2016 Jul 01; 36(7):810-20. PubMed ID: 26780945
    [Abstract] [Full Text] [Related]

  • 18. Fields of effects of 2 commercial preparations of botulinum toxin type A at equal labeled unit doses: a double-blind randomized trial.
    Hexsel D, Hexsel C, Siega C, Schilling-Souza J, Rotta FT, Rodrigues TC.
    JAMA Dermatol; 2013 Dec 01; 149(12):1386-91. PubMed ID: 24108521
    [Abstract] [Full Text] [Related]

  • 19. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW, Pijpe J, Jansma J.
    Int J Oral Maxillofac Surg; 2011 Feb 01; 40(2):127-33. PubMed ID: 20965695
    [Abstract] [Full Text] [Related]

  • 20. Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications.
    Rzany B, Fratila AA, Fischer TC, Hilton S, Pavicic T, Rothhaar A, Sattler G, Sommer B, Pickett A.
    J Drugs Dermatol; 2013 Jan 01; 12(1):80-4. PubMed ID: 23377332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.